Cervical cancer screening in Europe - Changes over the last 9 years

European Journal of Cancer

Volumn 45, Issue 15, 2009, Pages 2629-2631

  Ronco, Guglielmo ^a   Anttila, Ahti ^b  

^a CPO Piemonte   (Italy)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; WART VIRUS VACCINE;

ARTICLE; CANCER MORTALITY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; EUROPE; EUROPEAN UNION; HEALTH CARE QUALITY; HUMAN; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 70349436153     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.07.021     Document Type: Note

References (26)

1. IARC Working Group on Cervical Cancer Screening and UICC Project Group on the Evaluation of Screening Programmes for Cancer. Screening for cancer of the uterine cervix. Lyon: IARC Sci Publ., IARC; 1986. p. 1-315.
2. International Agency for Research on Cancer. Cervix cancer screening. IARC handbooks of cancer prevention vol. 10 (2005), IARC Press, Lyon p. 1-302
3. Linos A, Riza E, van Ballegooijen M, editors. Cervical cancer screening in the European Union. Eur J Cancer 2000;36(17):2175-75 [special issue].
4. Arbyn M., and Dillner J. HPV vaccination - an overview. In: Arbyn M., Anttila A., Jordan J., et al. (Eds). European guidelines for quality assurance in cervical cancer screening. European Communities (2008), Office for Official Publications of the European Union, Luxembourg 267-282
5. Naucler P., Ryd W., Törnberg S., et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357 16 (2007) 1589-1597
6. Bulkmans N.W.J., Berkhof J., Rozendaal L., et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet (2007) 10.1016/S0140-6736(07)61450-0
7. Kitchener H.C., Almonte M., Wheeler P., et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 95 1 (2006) 56-61 [Epub 2006 January 13]
8. Ronco G., Giorgi-Rossi P., Carozzi F., et al. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone to conventional cytology as the primary cervical cancer screening test. J Natl Cancer Inst 100 (2008) 492-501
9. Kotaniemi-Talonen L., Nieminen P., Anttila A., and Hakama M. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer 93 8 (2005) 862-867
10. De Vuyst H., Clifford G., Li N., and Franceschi S. HPV in Europe. Eur J Cancer 45 15 (2009) 2632-2639 [Special issue]
11. Arbyn M., Raifu A.O., Weiderpass E., Bray F., and Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 45 15 (2009) 2640-2648 [special issue]
12. Arbyn M., Autier P., and Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 18 (2007) 1423-1425
13. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 10 (2008) 1345-1389 [Epub 2008 February 14]
14. European Council. Council recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union 16.12.2003: L327/34-L327/38.
15. Arbyn M, Anttila A, Jordan J, et al. European guidelines for quality assurance in cervical cancer screening. European Communities. Luxembourg: Office for Official Publications of the European Union; 2008. p. 1-291.
16. Anttila A., von Karsa L., Aasmaa A., et al. Policies for cervical screening programmes in Europe. Eur J Cancer 45 15 (2009) 2649-2658 [special issue]
17. Ronco G., van Ballegooijen M., Becker N., et al. Process performance of cervical screening programmes in Europe. Eur J Cancer 45 15 (2009) 2659-2670 [special issue]
18. Working group on the registration and monitoring of cervical cancer screening programmes in the European Union. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009;45(15):2685-708 [special issue].
19. Arbyn M., Rebolj M., De Kok I., et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 45 15 (2009) 2671-2678 [special issue]
20. Nicula F.A., Anttila A., Neamtiu L., et al. Challenges in starting organised screening programmes for cervical cancer in the new member states. Eur J Cancer 45 15 (2009) 2679-2684 [special issue]
21. Lévy-Bruhl D., King L.A., O' Flanagan D., et al., and the country specific VENICE gate keepers and contact points. The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey. Eur J Cancer 45 15 (2009) 2709-2713 [special issue]
22. Lynge E., Anttila A., Arbyn M., Segnan N., and Ronco G. What's next? Perspectives and future needs of cervical screening in Europe in the era of molecular testing and vaccination. Eur J Cancer 45 15 (2009) 2714-2721 [special issue]
23. Von Karsa L, Anttila A, Ronco G, et al. Cancer screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening, 1st report. European Communities, printed in Luxembourg by the services of the European Commission, 2008. p. 1-137.
24. Van Ballegoijen M., van der Akker - van Marle E., Patnick J., et al. Overview of important cervical cancer screening process values in EU-countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. Eur J Cancer 36 17 (2000) 2177-2188 [special issue]
25. ; 2002.
26. Dillner J., Rebolj M., Birembaut P., et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 377 (2008) a1754 10.1126/bmj.a175